FOXQ1 knockdown inhibited the in vivo tumor formation of radio-resistant CRC cells through repressing CRC stemness and related intestinal bacteria via blocking the SIRT1/β-catenin axis. Here, FOXQ1 is linked to colorectal carcinoma.